Tasigna 150 mg hard capsules, Scemblix 40 mg film-coated tablets
CML1624
Phase 2 small_molecule active
Quick answer
Tasigna 150 mg hard capsules, Scemblix 40 mg film-coated tablets for BCR-ABL1+ Chronic Myeloid Leukemia is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- BCR-ABL1+ Chronic Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active